title: [The compound MCT-21 and its antihymenolepidose activity].
authors.forename: F S
authors.initials: FS
authors.lastname: Mikhaĭlitsyn
authors.forename: G A
authors.initials: GA
authors.lastname: Gitsu
authors.forename: D P
authors.initials: DP
authors.lastname: Sevbo
authors.forename: S N
authors.initials: SN
authors.lastname: Trusov
authors.forename: L A
authors.initials: LA
authors.lastname: Bolotina
mesh_terms: D000818:Animals; D000923:Anticestodal Agents / Q000737:chemistry / Q000627:therapeutic use*; D001549:Benzamides / Q000737:chemistry / Q000627:therapeutic use*; D001969:Bromobenzenes / Q000737:chemistry / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana / Q000187:drug effects*; D009578:Nitrobenzenes / Q000737:chemistry / Q000627:therapeutic use*
chemical_list: D000923:Anticestodal Agents; D001549:Benzamides; D001969:Bromobenzenes; C557695:N-(2-chloro-4-nitrophenyl)-2-acetoxy-3,5-dibromobenzamide; D009578:Nitrobenzenes